As of Feb 12
| +0.05 / +1.02%|
The 5 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 16.00, with a high estimate of 30.00 and a low estimate of 14.00. The median estimate represents a +222.58% increase from the last price of 4.96.
The current consensus among 7 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.